Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021846

CEO bought 48,076 shares at $0.52 ($25,000)

From the SEC's structured data for this filing

Trades in this filing

Woods Lori A · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-22 Purchase : show line 1 in the form +48,076 $0.52 $25,000 48,076 D
Open-market purchases · 48,076 sh · avg $0.52 · $25,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-22 Purchase : show line 2 in the form Warrant (right to buy) +24,038 611,538 D
Loading xslF345X03/rdgdoc.xml…